FDA Inspection 583012 — Advent Pharmaceuticals Inc.
The FDA completed an inspection of Advent Pharmaceuticals Inc. on Apr 30, 2009 in Hightstown, NJ. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Apr 30, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hightstown, NJ (United States)